CVS · Earnings call · 2026Q2T · Full report

Retail Pharmacy Pricing Pressure

CVS HEALTH Corp · 2026-08-05 · Importance 40 · Surprise 42

CVS Pharmacy is addressing reimbursement pressure through a cost-based pricing approach intended to produce more sustainable reimbursement and better align payers with the value of community pharmacy services. Pharmacy revenue growth was partly offset by regulatory-related price reductions on certain drugs, new generic introductions and pharmacy reimbursement pressure. Management said the company is providing industry-leading cost of goods to payers and is seeking a more consistent margin profile. The Rite Aid transaction supported near-term performance, but CVS expects durable growth to depend on service levels and differentiated solutions rather than only transaction-related share gains.